McIlrath & Eck’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-25
| Closed | -$4.62K | – | 946 |
|
|
2024
Q4 | $4.62K | Sell |
25
-10
| -29% | -$1.85K | ﹤0.01% | 773 |
|
|
2024
Q3 | $6.89K | Buy |
+35
| New | +$6.89K | ﹤0.01% | 697 |
|
|
2024
Q2 | – | Sell |
-28
| Closed | -$7.59K | – | 959 |
|
|
2024
Q1 | $7.59K | Hold |
28
| – | – | ﹤0.01% | 646 |
|
|
2023
Q4 | $6.62K | Hold |
28
| – | – | ﹤0.01% | 627 |
|
|
2023
Q3 | $5.49K | Hold |
28
| – | – | ﹤0.01% | 638 |
|
|
2023
Q2 | $5.89K | Hold |
28
| – | – | ﹤0.01% | 642 |
|
|
2023
Q1 | $5.65K | Hold |
28
| – | – | ﹤0.01% | 644 |
|
|
2022
Q4 | $6.1K | Hold |
28
| – | – | ﹤0.01% | 604 |
|
|
2022
Q3 | $6K | Hold |
28
| – | – | ﹤0.01% | 602 |
|
|
2022
Q2 | $6K | Hold |
28
| – | – | ﹤0.01% | 580 |
|
|
2022
Q1 | $8K | Hold |
28
| – | – | ﹤0.01% | 555 |
|
|
2021
Q4 | $11K | Hold |
28
| – | – | ﹤0.01% | 520 |
|
|
2021
Q3 | $12K | Hold |
28
| – | – | ﹤0.01% | 491 |
|
|
2021
Q2 | $10K | Hold |
28
| – | – | ﹤0.01% | 516 |
|
|
2021
Q1 | $8K | Hold |
28
| – | – | ﹤0.01% | 506 |
|
|
2020
Q4 | $7K | Hold |
28
| – | – | ﹤0.01% | 474 |
|
|
2020
Q3 | $6K | Hold |
28
| – | – | ﹤0.01% | 452 |
|
|
2020
Q2 | $5K | Buy |
+28
| New | +$5K | ﹤0.01% | 463 |
|